Breyanzi

BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Bristol Myers Squibb
CAR-T
CLL
Breyanzi
FDA
JNJ
Carvykti
ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a single-arm trial persuade the FDA?
Fierce Pharma
Fri, 05/26/23 - 09:57 am
ASCO 2023
Bristol Myers Squibb
Breyanzi
CAR-T
CLL
SLL
clinical trials
Bristol Myers dodges one $6.4B Celgene buyout CVR suit, but the battle is far from over
Fierce Pharma
Thu, 03/2/23 - 10:45 pm
Bristol Myers Squibb
Breyanzi
Celgene
legal
M&A
CVRs
Bristol Myers claims win with CAR-T therapy Breyanzi in leukemia
Endpoints
Thu, 01/26/23 - 05:09 pm
Bristol Myers Squibb
CAR-T
Breyanzi
CLL
cell therapy
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
Mon, 12/12/22 - 10:16 am
Bristol Myers Squibb
Breyanzi
B-cell lymphoma
CAR-T
ASH 2022
Even as Revlimid's star fades, Bristol Myers' core offerings have reached a 'critical mass,' CEO says
Fierce Pharma
Thu, 10/27/22 - 11:04 am
Bristol Myers Squibb
generics
Revlimid
Abecma
Breyanzi
Pharma CEOs
Giovanni Caforio
Federal judge denies Bristol Myers' attempt to avoid Celgene shareholder lawsuit
Endpoints
Mon, 06/27/22 - 07:02 pm
Celgene
Bristol Myers Squibb
Breyanzi
legal
Amidst Legal Battle, BMS' CAR-T Therapy Scores Second FDA Approval
BioSpace
Mon, 06/27/22 - 06:32 pm
Bristol Myers Squibb
CAR-T
Breyanzi
liso-cel
FDA
large B-cell lymphoma
'Major blunder:' Ex-staffers blast Bristol Myers Squibb's handling of Breyanzi approval in latest CVR lawsuit update
Fierce Pharma
Wed, 02/23/22 - 10:09 pm
Bristol Myers Squibb
legal
Breyanzi
shareholders
CAR-T
liso-cel
lymphoma
Bristol busy boosting supply of Breyanzi, Abecma as massive Revlimid patent cliff looms
Fierce Pharma
Fri, 02/4/22 - 11:22 am
Bristol Myers Squibb
CAR-T
Breyanzi
Abecma
JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff
Fierce Pharma
Mon, 01/10/22 - 11:49 pm
JPMHC 2022
Bristol Myers Squibb
Revlimid
patent cliffs
Opdivo
Eliquis
Reblozyl
Breyanzi
ASH: Bristol Myers' Breyanzi, Gilead's Yescarta lock horns in race to move CAR-T therapy to earlier lymphoma
Fierce Pharma
Sat, 12/11/21 - 09:22 pm
Gilead Sciences
Yescarta
Bristol Myers Squibb
Breyanzi
CAR-T
lymphoma
BMS will file for earlier-line use of Breyanzi in lymphoma after trial win
Pharmaforum
Fri, 06/11/21 - 10:49 am
Bristol Myers Squibb
CAR-T
Breyanzi
large B-cell lymphoma
Novartis
Gilead Sciences
FDA
Bristol Myers' CAR-T Breyanzi busts out a win in earlier-line lymphoma, potentially cracking open an expanded market
Endpoints
Thu, 06/10/21 - 10:50 am
Bristol-Myers Squibb
CAR-T
Breyanzi
B cell lymphoma
Bristol-Myers is sued for $6.4 billion over delayed cancer drug
Reuters
Thu, 06/3/21 - 11:14 pm
Bristol Myers Squibb
Breyanzi
legal
Celgene
Bristol Myers sees automation, virtual reality on the horizon for pair of new CAR-T manufacturing plants
Fierce Pharma
Mon, 05/3/21 - 11:11 am
Bristol Myers Squibb
CAR-T
drug manufacturing
Breyanzi
Abecma
Bristol Myers, with Breyanzi nod in hand, eyes faster cell therapy production
Fierce Pharma
Tue, 03/23/21 - 10:53 am
Bristol-Myers Squibb
cell therapy
Breyanzi
drug manufacturing
Novartis exec says Kymriah's ready to square off with Bristol Myers' new CAR-T rival Breyanzi
Fierce Pharma
Sun, 03/7/21 - 01:29 pm
Bristol Myers Squibb
Breyanzi
CAR-T
lymphoma
Novartis
Kymriah